Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib maintenance in advanced ovarian cancer
NCT02655016Phase 3Active, not recruiting
- Start
- Jul 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of niraparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC). Started Jul 2016; status: active, not recruiting.
02
Drugs
niraparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02655016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655016.